{"name": "Ception Therapeutics",
 "permalink": "ception-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/ception-therapeutics",
 "homepage_url": "http://www.ceptiontx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contactus@ceptiontx.com",
 "phone_number": "610.640.2940",
 "description": "",
 "created_at": "Wed Feb 24 03:11:12 UTC 2010",
 "updated_at": "Thu Mar 11 04:07:58 UTC 2010",
 "overview": "\u003Cp\u003ECeption Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need. \u003C/p\u003E\n\n\u003Cp\u003ECeption was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[149,
       150],
      "assets/images/resized/0007/7999/77999v1-max-150x150.png"],
     [[191,
       192],
      "assets/images/resized/0007/7999/77999v1-max-250x250.png"],
     [[191,
       192],
      "assets/images/resized/0007/7999/77999v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Stephen",
      "last_name": "Tullman",
      "permalink": "stephen-tullman",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Doug",
      "last_name": "Gessl",
      "permalink": "doug-gessl",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$77.7M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://ceptiontx.com/news/news001.htm",
    "source_description": "Ception Therapeutics Raises $63 Million in Series C Financing",
    "raised_amount": 63000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 1,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Growth Capital Fund",
         "permalink": "growth-capital-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MDS Capital",
         "permalink": "mds-capital",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Science Ventures",
         "permalink": "new-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               88],
              "assets/images/resized/0004/2733/42733v2-max-150x150.png"],
             [[158,
               93],
              "assets/images/resized/0004/2733/42733v2-max-250x250.png"],
             [[158,
               93],
              "assets/images/resized/0004/2733/42733v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aperture Venture Partners",
         "permalink": "aperture-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0006/2293/62293v1-max-150x150.jpg"],
             [[208,
               65],
              "assets/images/resized/0006/2293/62293v1-max-250x250.jpg"],
             [[208,
               65],
              "assets/images/resized/0006/2293/62293v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://ceptiontx.com/news/news003.htm",
    "source_description": "Ception Therapeutics Raises Additional $14.7 Million Bringing Total Series C Financing to $77 Million",
    "raised_amount": 14700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 31,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Third Point Ventures",
         "permalink": "third-point-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Greenlight Capital",
         "permalink": "greenlight-capital",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0007/9900/79900v1-max-150x150.jpg"],
             [[223,
               83],
              "assets/images/resized/0007/9900/79900v1-max-250x250.jpg"],
             [[223,
               83],
              "assets/images/resized/0007/9900/79900v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 250000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fiercebiotech.com/story/cephalon-pays-250m-snare-ception-therapeutics/2010-02-23?utm_medium=rss\u0026utm_source=rss",
   "source_description": "Cephalon pays $250M to snare Ception Therapeutics",
   "acquired_year": 2010,
   "acquired_month": 2,
   "acquired_day": 23,
   "acquiring_company":
    {"name": "Cephalon",
     "permalink": "cephalon",
     "image":
      {"available_sizes":
        [[[150,
           46],
          "assets/images/resized/0007/7997/77997v1-max-150x150.jpg"],
         [[233,
           73],
          "assets/images/resized/0007/7997/77997v1-max-250x250.jpg"],
         [[233,
           73],
          "assets/images/resized/0007/7997/77997v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "101 Lindenwood Drive",
    "address2": "Suite 400",
    "zip_code": "19355",
    "city": "Malvern",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        102],
       "assets/images/resized/0007/9897/79897v1-max-150x150.jpg"],
      [[250,
        170],
       "assets/images/resized/0007/9897/79897v1-max-250x250.jpg"],
      [[450,
        307],
       "assets/images/resized/0007/9897/79897v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}